ReWalk Robotics Ltd. (NASDAQ:RWLK)’s share price rose 11.7% during trading on Friday . The stock traded as high as $7.67 and last traded at $7.53, with a volume of 83,777 shares. The stock had previously closed at $6.74.

A number of equities research analysts have issued reports on RWLK shares. Zacks Investment Research upgraded shares of ReWalk Robotics from a “hold” rating to a “buy” rating and set a $11.00 target price on the stock in a report on Tuesday, May 10th. Jefferies Group reiterated a “buy” rating and set a $16.00 target price on shares of ReWalk Robotics in a report on Sunday, May 8th.

The stock has a 50 day moving average price of $7.18 and a 200-day moving average price of $9.46. The firm’s market cap is $90.93 million.

ReWalk Robotics (NASDAQ:RWLK) last announced its earnings results on Thursday, May 5th. The medical device company reported ($0.48) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.60) by $0.12. The business had revenue of $2.06 million for the quarter, compared to analyst estimates of $1.56 million. The business’s revenue was up 224.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.48) EPS. Equities research analysts predict that ReWalk Robotics Ltd. will post ($2.11) earnings per share for the current year.

In other ReWalk Robotics news, Director Jeff Dykan sold 11,370 shares of ReWalk Robotics stock in a transaction dated Wednesday, June 1st. The shares were sold at an average price of $7.74, for a total transaction of $88,003.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder Scp Vitalife Partners (Israel) sold 4,772 shares of ReWalk Robotics stock in a transaction dated Friday, June 3rd. The stock was sold at an average price of $7.89, for a total transaction of $37,651.08. The disclosure for this sale can be found here.

A hedge fund recently bought a new stake in ReWalk Robotics stock. EAM Investors LLC purchased a new position in ReWalk Robotics Ltd. (NASDAQ:RWLK) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 93,333 shares of the medical device company’s stock, valued at approximately $1,351,000. EAM Investors LLC owned about 0.77% of ReWalk Robotics at the end of the most recent quarter.

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk. The Company offers ReWalk, an exoskeleton that uses its tilt-sensor technology, and an on-board computer and motion sensors to drive motorized legs that power movement.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.